Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Community Health. 2016 Apr;41(2):274–281. doi: 10.1007/s10900-015-0093-2

Figure 2.

Figure 2

Community-level prevalence of human papillomavirus (HPV) vaccine completion (three doses) among Hopi girls according to age (2007–2013). For each data point, the denominator was defined as the number of girls in each age range who had made at least two visits to the Hopi Health Care Center within three years before February 1 of each calendar year, and the numerator was defined as the number who had completed the HPV vaccine series as of February 1. Error bars represent 95% confidence intervals.